Чланци са овлашћеним јавним приступом - Teri E. KleinСазнајте више
Није доступно нигде: 2
The association of obesity and coronary artery disease genes with response to SSRIs treatment in major depression
AT Amare, KO Schubert, F Tekola-Ayele, YH Hsu, K Sangkuhl, G Jenkins, ...
Journal of Neural Transmission 126, 35-45, 2019
Овлашћења: US National Institutes of Health, Federal Ministry of Education and Research …
Pharmacogenetic resources: PharmGKB and Clinical Pharmacogenetics implementation consortium
M Whirl-Carrillo, TE Klein
Pharmacy Times 82 (9), 84-87, 2016
Овлашћења: US National Institutes of Health
Доступно негде: 244
Pharmacogenomics knowledge for personalized medicine
M Whirl‐Carrillo, EM McDonagh, JM Hebert, L Gong, K Sangkuhl, ...
Clinical Pharmacology & Therapeutics 92 (4), 414-417, 2012
Овлашћења: US National Institutes of Health
Doxorubicin pathways: pharmacodynamics and adverse effects
CF Thorn, C Oshiro, S Marsh, T Hernandez-Boussard, H McLeod, ...
Pharmacogenetics and genomics 21 (7), 440-446, 2011
Овлашћења: US National Institutes of Health
Estimation of the warfarin dose with clinical and pharmacogenetic data
International Warfarin Pharmacogenetics Consortium
New England Journal of Medicine 360 (8), 753-764, 2009
Овлашћења: US National Institutes of Health
Recommendations for reporting of secondary findings in clinical exome and genome sequencing, 2016 update (ACMG SF v2. 0): a policy statement of the American College of Medical …
SS Kalia, K Adelman, SJ Bale, WK Chung, C Eng, JP Evans, GE Herman, ...
Genetics in medicine 19 (2), 249-255, 2017
Овлашћења: US National Institutes of Health
Personal omics profiling reveals dynamic molecular and medical phenotypes
R Chen, GI Mias, J Li-Pook-Than, L Jiang, HYK Lam, R Chen, E Miriami, ...
Cell 148 (6), 1293-1307, 2012
Овлашћења: US National Institutes of Health, Government of Spain
CPIC: clinical pharmacogenetics implementation consortium of the pharmacogenomics research network
MV Relling, TE Klein
Clinical Pharmacology & Therapeutics 89 (3), 464-467, 2011
Овлашћења: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C19 Genotype and Clopidogrel Therapy: 2013 Update
SA Scott, K Sangkuhl, CM Stein, JS Hulot, JL Mega, DM Roden, TE Klein, ...
Clinical Pharmacology & Therapeutics 94 (3), 317-323, 2013
Овлашћења: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guideline for CYP2D6 and CYP2C19 Genotypes and Dosing of Selective Serotonin Reuptake …
JK Hicks, JR Bishop, K Sangkuhl, DJ Müller, Y Ji, SG Leckband, ...
Clinical Pharmacology & Therapeutics 98 (2), 127-134, 2015
Овлашћења: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium guidelines for thiopurine methyltransferase genotype and thiopurine dosing
MV Relling, EE Gardner, WJ Sandborn, K Schmiegelow, CH Pui, SW Yee, ...
Clinical Pharmacology & Therapeutics 89 (3), 387-391, 2011
Овлашћења: US National Institutes of Health
Clinical assessment incorporating a personal genome
EA Ashley, AJ Butte, MT Wheeler, R Chen, TE Klein, FE Dewey, ...
The Lancet 375 (9725), 1525-1535, 2010
Овлашћења: US National Institutes of Health, Howard Hughes Medical Institute, John D …
Clinical Pharmacogenetics Implementation Consortium Guidelines for CYP2C9 and VKORC1 Genotypes and Warfarin Dosing
JA Johnson, L Gong, M Whirl‐Carrillo, BF Gage, SA Scott, CM Stein, ...
Clinical Pharmacology & Therapeutics 90 (4), 625-629, 2011
Овлашћења: US National Institutes of Health, Swedish Research Council
Clinical Pharmacogenetics Implementation Consortium (CPIC) Guidelines for CYP3A5 Genotype and Tacrolimus Dosing
KA Birdwell, B Decker, JM Barbarino, JF Peterson, CM Stein, W Sadee, ...
Clinical Pharmacology & Therapeutics 98 (1), 19-24, 2015
Овлашћења: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium guidelines for cytochrome P450 2D6 genotype and codeine therapy: 2014 update
KR Crews, A Gaedigk, HM Dunnenberger, JS Leeder, TE Klein, ...
Clinical Pharmacology & Therapeutics 95 (4), 376-382, 2014
Овлашћења: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for pharmacogenetics‐guided warfarin dosing: 2017 update
JA Johnson, KE Caudle, L Gong, M Whirl‐Carrillo, CM Stein, SA Scott, ...
Clinical Pharmacology & Therapeutics 102 (3), 397-404, 2017
Овлашћења: US National Institutes of Health, Swedish Research Council, UK Medical …
Clinical pharmacogenetics implementation consortium guideline (CPIC®) for CYP2D6 and CYP2C19 genotypes and dosing of tricyclic antidepressants: 2016 update
JK Hicks, K Sangkuhl, JJ Swen, VL Ellingrod, DJ Müller, K Shimoda, ...
Clinical pharmacology and therapeutics 102 (1), 37, 2017
Овлашћења: US National Institutes of Health, Canadian Institutes of Health Research
Metformin pathways: pharmacokinetics and pharmacodynamics
L Gong, S Goswami, KM Giacomini, RB Altman, TE Klein
Pharmacogenetics and genomics 22 (11), 820-827, 2012
Овлашћења: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium (CPIC) guideline for dihydropyrimidine dehydrogenase genotype and fluoropyrimidine dosing: 2017 update
U Amstutz, LM Henricks, SM Offer, J Barbarino, JHM Schellens, JJ Swen, ...
Clinical Pharmacology & Therapeutics 103 (2), 210-216, 2018
Овлашћења: US National Institutes of Health
Clinical Pharmacogenetics Implementation Consortium Guideline for Thiopurine Dosing Based on TPMT and NUDT15 Genotypes: 2018 Update
MV Relling, M Schwab, M Whirl‐Carrillo, G Suarez‐Kurtz, CH Pui, ...
Clinical Pharmacology & Therapeutics 105 (5), 1095-1105, 2019
Овлашћења: US National Institutes of Health
Публикације и информације о финансирању аутоматски одређује рачунарски програм